SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paullie who wrote (4773)3/30/1999 9:21:00 PM
From: Richard Nisbet  Read Replies (1) of 57584
 
Rande, Will, Da Bard, Due Dilligence....

FSON...trading at 5 1/4....biotech makes surgical sealants...already completed phase III testing....and 1st module under the new FDA modular approval plan....Second module has been sent to the FDA...approval eta probably late 2nd Q or 3rd Q...

Rumor on news coming soon....CE Mark approval for Europe most likely next month or May at the latest....market estimated at 700 million for its Floseal matrix...might be something to DD on...or buy into at these prices....when the 1st module approval was announced this stock ran from $4 - $12....that was in November...a suggestion from a poor teacher....:)

please...anything you can add...opinion or factual...feel free to let me know....Im in long...at least long till the FDA approves us...and if it goes to $30 + then we'll see :)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext